Peripheral T-cell lymphoma after anti-CD20 antibody therapy [4] (multiple letters)

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1635-1637

  Tetreault, Scott ^a   Abler, Sandy L ^a   Robbins, Bruce ^a   Saven, Alan ^a   Maloney, David G ^a   Davis, Thomas ^a   Levy, Ronald ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CHLORAMBUCIL; MONOCLONAL ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

AGED; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL TRIAL; FEMALE; HUMAN; LETTER; LYMPH NODE BIOPSY; LYMPHOCYTE DEPLETION; MALIGNANT TRANSFORMATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SPLENECTOMY; T CELL LYMPHOMA;

EID: 0031924421     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1635     Document Type: Letter

References (0)